The ADEAR Training Program is now accepting applications for postdoctoral training in HIV/AIDS-related research for the 2020-21 academic year. This integrative program provides multidisciplinary training in basic, translational, and clinical science in human immunodeficiency virus type 1 (HIV)/AIDS research. The Postdoctoral scientist will receive training under the direction of a broadly based group of faculty at the University of Colorado campuses in Aurora, Boulder, and Denver, Colorado State University and Denver University. The training program faculty are experienced mentors and actively engaged in research related to discovering and evaluating new antiretroviral drugs or applying existing antiretrovirals for the treatment and prevention of HIV/AIDS.
More information about participating institutions can be found on their respective websites:
- University of Colorado – Anschutz Medical Campus
- Colorado State University
- University of Colorado – Boulder
- University of Colorado – Denver
- University of Denver
According to NIH guidelines, trainees receive salary and benefits support, travel funds, and funds to pay for training-related coursework. Support is typically provided for two years, contingent on progress in the first year. An additional year of support can be requested at the end of year two. Award of a third year of support is contingent on approval of the Training Program Steering Committee.
All applicants must:
- Hold a terminal degree in their field (e.g., DDS, DO, DNP, DVM, MD, PharmD, and/or PhD).
- Be a U.S. citizen or a permanent U.S. resident “Green Card” holder.
- Be committed to a career as an investigator in HIV-related research.
- Be able to devote full-time effort to the training program during the period of support.
- The applicant’s mentor has to be a full-time faculty at one of the above mentioned institutions and hold an R01 or equivalent funding during the training period.
General instructions, criteria, and selection process:
- Please refer to the NIH web site for specific Institutional NRSA (T32) details and requirements. All candidates must agree to applicable payback stipulations in the T32 regulations.
- All candidates should have completed their terminal degree, have not received independent funding, and have a proposed mentored research project related to the discovery and evaluation of new antiretroviral drugs or the application of existing antiretrovirals for the treatment and prevention of HIV/AIDS.
- All recipients will be encouraged to submit at least one additional grant during the funding cycle.
- All candidates doing human subject research are required to have passed the NIH required human subjects training and test (CITI Basic) and have approval from the IRB and CTRC (if appropriate) before initiating the research.
- All candidates are expected to include appropriate (recently revised) training in responsible conduct of research per NIH Grants Policy Statement (see below).
- Co-mentoring between senior and junior level faculty is encouraged.
- Underrepresented minority, disabled, or disadvantaged candidates are especially encouraged to apply.
- All proposals should relate to the high priority topics for HIV/AIDS research.